{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T20:27:41Z","timestamp":1769718461638,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.ijantimicag.2009.09.029","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T10:09:27Z","timestamp":1261044567000},"page":"146-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus"],"prefix":"10.1016","volume":"35","author":[{"given":"Peter A.","family":"Warn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Morrissey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Denning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2009.09.029_bib1","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/clinids\/23.3.608","article-title":"Therapeutic outcome in invasive aspergillosis","volume":"23","author":"Denning","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-4453(96)92700-0","article-title":"Trends in the postmortem epidemiology of invasive fungal infections at a university hospital","volume":"33","author":"Groll","year":"1996","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/322606","article-title":"Trends in mortality due to invasive mycotic diseases in the United States, 1980\u20131997","volume":"33","author":"McNeil","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib5","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/517849","article-title":"Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality\u2014SEIFEM-C Report","volume":"44","author":"Pagano","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib6","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1086\/592255","article-title":"Factors associated with overall and attributable mortality in invasive aspergillosis","volume":"47","author":"Nivoix","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1086\/324620","article-title":"Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis","volume":"34","author":"Denning","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2147\/TCRM.S3329","article-title":"Posaconazole in the management of refractory invasive fungal infections","volume":"4","author":"Langner","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/AAC.44.1.57-62.2000","article-title":"In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi","volume":"44","author":"Tawara","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/AAC.44.3.614-618.2000","article-title":"Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis","volume":"44","author":"Ikeda","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib11","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/AAC.41.11.2333","article-title":"Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis","volume":"41","author":"Abruzzo","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib12","series-title":"Abstracts of the 41st interscience conference on antimicrobial agents and chemotherapy (ICAAC), 16\u201319 December 2001, Chicago, IL","article-title":"In vitro activity of HMR3270 against Candida sp.","author":"Moore","year":"2001"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/AAC.47.4.1187-1192.2003","article-title":"In vivo pharmacodynamics of HMR 3270, a glucan synthase inhibitor, in a murine candidiasis model","volume":"47","author":"Andes","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib14","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/jac\/dki268","article-title":"Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis","volume":"56","author":"Warn","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib15","series-title":"Abstracts of the 41st interscience conference on antimicrobial agents and chemotherapy (ICAAC), 16\u201319 December 2001, Chicago, IL","article-title":"The in vivo activity of HMR3270 in temporarily neutropenic murine models of disseminated infection caused by Aspergillus fumigatus (2 strains)","author":"Warn","year":"2001"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib16","doi-asserted-by":"crossref","unstructured":"Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing. EUCAST technical note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin Microbiol Infect 2008;14:982\u20134 [Erratum in: Clin Microbiol Infect 2009;15:103].","DOI":"10.1111\/j.1469-0691.2008.02086.x"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib17","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1469-0691.2007.01790.x","volume":"13","author":"Cuenca-Estrella","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib18","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkg185","article-title":"Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B","volume":"51","author":"Warn","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/jac\/40.3.401","article-title":"Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection","volume":"40","author":"Denning","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib20","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0002-9343(89)90475-0","article-title":"Treatment of invasive aspergillosis with itraconazole","volume":"86","author":"Denning","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jac\/45.1.85","article-title":"Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection","volume":"45","author":"Johnson","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib22","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ijantimicag.2006.08.017","article-title":"Multi-azole resistance in Aspergillus fumigatus","volume":"28","author":"Howard","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib23","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","author":"Snelders","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib24","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1128\/AAC.41.11.2326","article-title":"In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)","volume":"41","author":"Bartizal","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1099\/0022-1317-49-7-601","article-title":"Amphotericin B resistance of Aspergillus terreus in a murine model of disseminated aspergillosis","volume":"49","author":"Dannaoui","year":"2000","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib26","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1128\/AAC.41.7.1504","article-title":"Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus","volume":"41","author":"Oakley","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/mmy.38.3.209.212","article-title":"Effect of grapefruit juice on serum voriconazole concentrations in the mouse","volume":"38","author":"Sugar","year":"2000","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib28","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1128\/AAC.46.9.3001-3012.2002","article-title":"The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro","volume":"46","author":"Bowman","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib29","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1128\/AAC.45.12.3474-3481.2001","article-title":"Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate","volume":"45","author":"Bowman","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/AAC.42.4.873","article-title":"Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosis","volume":"42","author":"Verweij","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib31","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1128\/JCM.41.12.5676-5682.2003","article-title":"Development and validation of a quantitative real-time PCR assay using fluorescence resonance energy transfer technology for detection of Aspergillus fumigatus in experimental invasive pulmonary aspergillosis","volume":"41","author":"O'Sullivan","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/jac\/dkh153","article-title":"Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and Candida","volume":"53","author":"Warn","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib33","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1128\/AAC.01601-08","article-title":"Pharmacokinetics and pharmacodynamics of a novel triazole, isavuconazole: mathematical modeling, importance of tissue concentrations, and impact of immune status on antifungal effect","volume":"53","author":"Warn","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/589304","article-title":"Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal \u03b2-glucan exposure","volume":"198","author":"Hohl","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib35","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1002\/cncr.22348","article-title":"Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis","volume":"107","author":"Maertens","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijantimicag.2009.09.029_bib36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jinf.2006.03.003","article-title":"Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis","volume":"53","author":"Denning","year":"2006","journal-title":"J Infect"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909004877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909004877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:30:37Z","timestamp":1760376637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857909004877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0924857909004877"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.09.029","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}